

Molecular diagnostic tests will increasingly be used for cancer screening, diagnosis, staging, therapy selection and relapse monitoring.
Molecular diagnostics is the fastest-growing segment of the in vitro diagnostics industry and cancer molecular diagnostics in particular represents a market forecasted to grow at in excess of thirty percent per year.
A relatively large number of molecular diagnostics manufacturing companies exist today. This unique report profiles the Top 60 Cancer Molecular Diagnostics Companies worldwide. These are the companies with the experience, know-how and resources to enable them to bring to market, cutting-edge and industry leading tests, reagents, technologies, instrumentation, platforms, systems and software.
Some Of The Cancers That The Companies In This Report Manufacture Tests For: Colorectal, Prostate, Breast, Melanoma, Lung, Bladder, Head And Neck, Renal, Cervical, Leukaemia, Endometrial, Pancreatic, Brain, Ovarian.
Usage: competitive analysis and partner/alliance identification.
The Top 60 Cancer Molecular Diagnostics Companies is of great interest to cancer research centres and university medical research facilities.
As it identifies all the leading cancer molecular diagnostics tests, reagents, technologies, instrumentation, platforms, systems and software and the companies that manufacture them, the report is a perfect reference tool for laboratories carrying out cancer molecular diagnostics tests.
This report is very useful to those pharmaceutical and biotechnology companies that are interested in pharmacogenomics and developing personalised medicines.
This report is invaluable to distributors in sourcing all the newest, best and therefore most in demand cancer molecular diagnostics products.
This report is ideal for suppliers to molecular diagnostics manufacturing companies who wish to identify top potential customers.
Note: Most people will be fully aware of the major players in this industry like Epigenomics AG etc. but this report looks at all 60 of the top companies.
The Top 60 Cancer Molecular Diagnostics Companies is the seventh in a highly successful series of in-vitro diagnostics reports by Research Facts.
Research Facts' reports help you make informed decisions about the markets and organisations that affect your business.
Hardcopy: Bound report, A4 format, 124 pages
Electronic: pdf Version, A4 format, 124 pages
Site License Version: Allows you to post this report on your Intranet/Knowledge Management System, allowing all employees in your organisation to access the report electronically.
Author: The scientific advisor on this report was Katie Ryan. Katie has advanced degrees in physiology and molecular medicine from Trinity College Dublin and is a member of the Department of Physiology there.